Heron Therapeutics IncNASDAQ:HRTX
- LAST PRICE1.9050
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.8700/ 10
- Ask / Lots1.9700/ 12
- Open / Previous Close0.0000 / 1.9050
- Day Range---
- 52 Week Range
- Volume3,655
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HRTX |
|---|---|---|
| 09:32 ET | 134559 | 2.068 |
| 09:34 ET | 96764 | 2.02 |
| 09:36 ET | 54895 | 1.965 |
| 09:38 ET | 73327 | 1.925 |
| 09:39 ET | 51532 | 1.9236 |
| 09:41 ET | 54114 | 1.88 |
| 09:43 ET | 15857 | 1.909 |
| 09:45 ET | 70565 | 1.9 |
| 09:48 ET | 14505 | 1.88 |
| 09:50 ET | 23658 | 1.89 |
| 09:52 ET | 16859 | 1.9 |
| 09:54 ET | 23214 | 1.93 |
| 09:56 ET | 24914 | 1.935 |
| 09:57 ET | 19902 | 1.91 |
| 09:59 ET | 45225 | 1.89 |
| 10:01 ET | 9134 | 1.9 |
| 10:03 ET | 28463 | 1.885 |
| 10:06 ET | 30730 | 1.8599 |
| 10:08 ET | 29203 | 1.84 |
| 10:10 ET | 74313 | 1.85 |
| 10:12 ET | 14659 | 1.84 |
| 10:14 ET | 16665 | 1.84 |
| 10:15 ET | 41975 | 1.8389 |
| 10:17 ET | 26957 | 1.825 |
| 10:19 ET | 16148 | 1.825 |
| 10:21 ET | 17184 | 1.829 |
| 10:24 ET | 25396 | 1.81 |
| 10:26 ET | 61953 | 1.8083 |
| 10:28 ET | 66504 | 1.835 |
| 10:30 ET | 9149 | 1.835 |
| 10:32 ET | 34524 | 1.83 |
| 10:33 ET | 23960 | 1.8471 |
| 10:35 ET | 25488 | 1.8601 |
| 10:37 ET | 8286 | 1.84 |
| 10:39 ET | 26800 | 1.83 |
| 10:42 ET | 17926 | 1.82 |
| 10:44 ET | 5255 | 1.8185 |
| 10:46 ET | 6212 | 1.81 |
| 10:48 ET | 44982 | 1.8277 |
| 10:50 ET | 41326 | 1.845 |
| 10:51 ET | 33324 | 1.88 |
| 10:53 ET | 10100 | 1.875 |
| 10:55 ET | 15634 | 1.8415 |
| 10:57 ET | 14077 | 1.85 |
| 11:00 ET | 9430 | 1.8468 |
| 11:02 ET | 2320 | 1.845 |
| 11:04 ET | 3525 | 1.8485 |
| 11:06 ET | 28746 | 1.8701 |
| 11:08 ET | 11157 | 1.8685 |
| 11:09 ET | 2784 | 1.865 |
| 11:11 ET | 4564 | 1.85 |
| 11:13 ET | 22167 | 1.84 |
| 11:15 ET | 29330 | 1.84 |
| 11:18 ET | 4439 | 1.84 |
| 11:20 ET | 3552 | 1.82 |
| 11:22 ET | 10572 | 1.82 |
| 11:24 ET | 9422 | 1.82 |
| 11:26 ET | 26659 | 1.8499 |
| 11:27 ET | 5738 | 1.8389 |
| 11:29 ET | 14093 | 1.825 |
| 11:31 ET | 2520 | 1.825 |
| 11:33 ET | 27391 | 1.815 |
| 11:36 ET | 2727 | 1.815 |
| 11:38 ET | 20471 | 1.83 |
| 11:40 ET | 2386 | 1.83 |
| 11:42 ET | 1350 | 1.8299 |
| 11:44 ET | 2470 | 1.83 |
| 11:45 ET | 12130 | 1.825 |
| 11:47 ET | 8604 | 1.825 |
| 11:49 ET | 6855 | 1.8299 |
| 11:51 ET | 3250 | 1.83 |
| 11:54 ET | 2350 | 1.83 |
| 11:56 ET | 1800 | 1.82 |
| 11:58 ET | 10854 | 1.825 |
| 12:00 ET | 3900 | 1.825 |
| 12:02 ET | 11300 | 1.8298 |
| 12:03 ET | 32118 | 1.8515 |
| 12:05 ET | 19215 | 1.845 |
| 12:07 ET | 10600 | 1.845 |
| 12:09 ET | 5204 | 1.8499 |
| 12:12 ET | 5106 | 1.845 |
| 12:14 ET | 4955 | 1.83 |
| 12:16 ET | 5550 | 1.83 |
| 12:18 ET | 3592 | 1.83 |
| 12:20 ET | 14191 | 1.83 |
| 12:21 ET | 6680 | 1.82 |
| 12:23 ET | 1720 | 1.825 |
| 12:25 ET | 20516 | 1.82 |
| 12:27 ET | 2441 | 1.8101 |
| 12:30 ET | 6400 | 1.8111 |
| 12:32 ET | 8859 | 1.815 |
| 12:34 ET | 5079 | 1.8189 |
| 12:36 ET | 9958 | 1.815 |
| 12:38 ET | 3087 | 1.81 |
| 12:39 ET | 1998 | 1.815 |
| 12:41 ET | 9096 | 1.82 |
| 12:43 ET | 36102 | 1.835 |
| 12:45 ET | 13195 | 1.85 |
| 12:48 ET | 1359 | 1.85 |
| 12:50 ET | 9491 | 1.8408 |
| 12:52 ET | 30462 | 1.86 |
| 12:54 ET | 493 | 1.86 |
| 12:56 ET | 10812 | 1.87 |
| 12:57 ET | 14200 | 1.88 |
| 12:59 ET | 13715 | 1.8708 |
| 01:01 ET | 2573 | 1.8797 |
| 01:03 ET | 1842 | 1.875 |
| 01:06 ET | 5929 | 1.875 |
| 01:08 ET | 8900 | 1.87 |
| 01:10 ET | 13700 | 1.865 |
| 01:12 ET | 3295 | 1.865 |
| 01:14 ET | 300 | 1.865 |
| 01:15 ET | 35028 | 1.9079 |
| 01:17 ET | 14307 | 1.905 |
| 01:19 ET | 9853 | 1.915 |
| 01:21 ET | 4700 | 1.93 |
| 01:24 ET | 11409 | 1.935 |
| 01:26 ET | 13052 | 1.915 |
| 01:28 ET | 730 | 1.9114 |
| 01:30 ET | 6898 | 1.915 |
| 01:32 ET | 897 | 1.92 |
| 01:33 ET | 18913 | 1.925 |
| 01:35 ET | 12506 | 1.93 |
| 01:37 ET | 14373 | 1.93 |
| 01:39 ET | 3367 | 1.93 |
| 01:42 ET | 3100 | 1.9302 |
| 01:44 ET | 15424 | 1.93 |
| 01:46 ET | 2150 | 1.93 |
| 01:48 ET | 25776 | 1.91 |
| 01:50 ET | 53324 | 1.891 |
| 01:51 ET | 17676 | 1.89 |
| 01:53 ET | 33128 | 1.905 |
| 01:55 ET | 7489 | 1.9299 |
| 01:57 ET | 16552 | 1.9281 |
| 02:00 ET | 10738 | 1.935 |
| 02:02 ET | 12927 | 1.94 |
| 02:04 ET | 22422 | 1.935 |
| 02:06 ET | 15140 | 1.92 |
| 02:08 ET | 2200 | 1.92 |
| 02:09 ET | 2700 | 1.92 |
| 02:11 ET | 47651 | 1.9299 |
| 02:13 ET | 3001 | 1.925 |
| 02:15 ET | 11069 | 1.93 |
| 02:18 ET | 10330 | 1.93 |
| 02:20 ET | 7010 | 1.94 |
| 02:22 ET | 28971 | 1.935 |
| 02:24 ET | 16837 | 1.935 |
| 02:26 ET | 12379 | 1.9212 |
| 02:27 ET | 3125 | 1.925 |
| 02:29 ET | 4643 | 1.925 |
| 02:31 ET | 6749 | 1.92 |
| 02:33 ET | 1378 | 1.92 |
| 02:36 ET | 2800 | 1.92 |
| 02:38 ET | 6100 | 1.92 |
| 02:40 ET | 3920 | 1.92 |
| 02:42 ET | 6223 | 1.92 |
| 02:44 ET | 4923 | 1.925 |
| 02:45 ET | 2746 | 1.925 |
| 02:47 ET | 1400 | 1.92 |
| 02:49 ET | 1600 | 1.925 |
| 02:51 ET | 2649 | 1.93 |
| 02:54 ET | 55211 | 1.905 |
| 02:56 ET | 9303 | 1.895 |
| 02:58 ET | 17391 | 1.875 |
| 03:00 ET | 1450 | 1.88 |
| 03:02 ET | 2411 | 1.875 |
| 03:03 ET | 4556 | 1.865 |
| 03:05 ET | 31614 | 1.8799 |
| 03:07 ET | 106318 | 1.875 |
| 03:09 ET | 9180 | 1.875 |
| 03:12 ET | 12097 | 1.875 |
| 03:14 ET | 71382 | 1.885 |
| 03:16 ET | 50254 | 1.895 |
| 03:18 ET | 8039 | 1.895 |
| 03:20 ET | 40069 | 1.905 |
| 03:21 ET | 20242 | 1.915 |
| 03:23 ET | 55511 | 1.92 |
| 03:25 ET | 68461 | 1.905 |
| 03:27 ET | 7599 | 1.905 |
| 03:30 ET | 13458 | 1.925 |
| 03:32 ET | 17411 | 1.935 |
| 03:34 ET | 14413 | 1.915 |
| 03:36 ET | 35930 | 1.905 |
| 03:38 ET | 31597 | 1.915 |
| 03:39 ET | 4759 | 1.9115 |
| 03:41 ET | 13752 | 1.9 |
| 03:43 ET | 38482 | 1.93 |
| 03:45 ET | 17994 | 1.925 |
| 03:48 ET | 10838 | 1.93 |
| 03:50 ET | 9657 | 1.925 |
| 03:52 ET | 37516 | 1.925 |
| 03:54 ET | 31499 | 1.905 |
| 03:56 ET | 25884 | 1.9 |
| 03:57 ET | 34483 | 1.905 |
| 03:59 ET | 53521 | 1.905 |
Mar 24, 2023
Evercore ISI Adjusts Price Target on Heron Therapeutics to $10 From $15, Maintains Outperform Rating, from 12:08PM ET on Friday Mar 24, 2023 by MT Newswires
12:08PM ET on Friday Mar 24, 2023 by MT NewswiresNeedham Adjusts Price Target on Heron Therapeutics to $7 From $8, Keeps Buy Rating, from 7:50AM ET on Friday Mar 24, 2023 by MT Newswires
7:50AM ET on Friday Mar 24, 2023 by MT Newswires
Mar 23, 2023
Heron Therapeutics Q4 Loss Narrows, Sales Jump; Shares Climb After Hours, from 4:56PM ET on Thursday Mar 23, 2023 by MT Newswires
4:56PM ET on Thursday Mar 23, 2023 by MT Newswires-- Earnings Flash (HRTX) HERON THERAPEUTICS Posts Q4 Revenue $30M, vs. Street Est of $27.2M, from 4:09PM ET on Thursday Mar 23, 2023 by MT Newswires
4:09PM ET on Thursday Mar 23, 2023 by MT NewswiresBRIEF-Heron Therapeutics Announces Results For Three Months Ended December 31, 2022 , from 4:08PM ET on Thursday Mar 23, 2023 by Thomson Reuters
4:08PM ET on Thursday Mar 23, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Heron Therapeutics Inc | 226.5M | -0.9x | --- |
Genfit SA | 198.6M | 5.6x | --- |
Selecta Biosciences Inc | 216.2M | 5.2x | --- |
Urogen Pharma Ltd | 193.7M | -1.8x | --- |
Innate Pharma SA | 224.0M | -3.7x | --- |
Sorrento Therapeutics Inc | 187.4M | -0.3x | --- |
Company Information
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. CINVANTI is an intravenous (IV) formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist. Its acute care product portfolio includes ZYNRELEF (HTX-011), HTX-019, and HTX-034. HTX-011 is a dual-acting local anaesthetic that delivers a fixed-dose combination of the local anaesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam. HTX-019 is an investigational agent for the prevention of postoperative nausea and vomiting. HTX-034 is a product candidate for postoperative pain management.
Contact Information
- Headquarters
- 4242 Campus Point Court, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-251-4400
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Barry Quart
- President, Chief Commercial Officer
- John Poyhonen
- Chief Operating Officer, Executive Vice President
- David Szekeres
- Senior Vice President - Pharmaceutical and Translational Sciences, Chief Scientific Officer
- Thomas Ottoboni
- Senior Vice President of Human Resources
- Sean Ristine
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $226.5M |
|---|---|
Revenue (TTM) | $98.3M |
Shares Outstanding | 118.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.95 |
EPS | $-2.09 |
Book Value | $0.76 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -211.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
